---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-017585"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:40:46.445704+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Select Medical reports Q4 growth, 2026 outlook; Ortenzio take-private bid under review

## Summary
- Q4 revenue $1,396.6M (+6.4%), net income $37.7M, diluted EPS $0.16 vs loss $0.19 YoY.
- FY2025 revenue $5,452.8M (+5.1%), net income $214.5M (+65%), adjusted EPS $1.16 (+23.4%).
- Rehab hospital segment revenue +15.2%, Adj EBITDA +11.1%. Outpatient rehab margin fell to 3.4% from 8.3%.
- 2026 outlook: revenue $5.6-5.8B, Adj EBITDA $520-540M, diluted EPS $1.22-1.32.
- Board declares $0.0625 dividend; $1B stock repurchase authorized through Dec 2027; Ortenzio take-private proposal under review.

## SEC filing metadata
- accession: 0001104659-26-017585
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465926017585/0001104659-26-017585-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465926017585/tm266741d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-017585
- JSON: https://secwatch.observer/filing/0001104659-26-017585.json
- Plain text: https://secwatch.observer/filing/0001104659-26-017585.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.